Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure: A Consensus Statement From the American Heart Association and American Diabetes Association

By R. Nesto, D. Bell, R. Bonow, V. Fonseca, S. Grundy, E. Horton, M. Le Winter, D. Porte, C. Semenkovich, Sidney C. Smith and 2 more. Diabetes Care, 2003

972 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Complementary and alternative medicine, Nephrology

View Paper: https://www.semanticscholar.org/paper/98fb294881d1f71b3d989a4f441e4fcf0e716e3e

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. G. Fonarow
2. T. Horwich
3. J. Januzzi
4. C. Yancy
5. M. Drazner
6. Véronique L. Roger
7. M. Gheorghiade

Citations in the corpus

• 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. (2013, background): “, rosiglitazone) is associated with fluid retention in patients with HF (129,132) and should be avoided in patients with NYHA class II through IV HF.”